A chronotherapeutics-applicable multi-target therapeutics based on AI: Example of therapeutic hypothermia

Author:

Liu Fei123,Jiang Xiangkang123,Yang Jingyuan123,Tao Jiawei123,Zhang Mao123ORCID

Affiliation:

1. Department of Emergency Medicine, Second Affiliated Hospital of Zhejiang University , Hangzhou 310009, Zhejiang Province, China

2. Institute of Emergency Medicine, Zhejiang University , Hangzhou 310009, Zhejiang Province, China

3. Key Laboratory of The Diagnosis and Treatment of Severe Trauma and Burn of Zhejiang Province, Zhejiang University , Hangzhou 310009, Zhejiang Province, China

Abstract

Abstract Nowadays, the complexity of disease mechanisms and the inadequacy of single-target therapies in restoring the biological system have inevitably instigated the strategy of multi-target therapeutics with the analysis of each target individually. However, it is not suitable for dealing with the conflicts between targets or between drugs. With the release of high-precision protein structure prediction artificial intelligence, large-scale high-precision protein structure prediction and docking have become possible. In this article, we propose a multi-target drug discovery method by the example of therapeutic hypothermia (TH). First, we performed protein structure prediction for all protein targets of each group by AlphaFold2 and RoseTTAFold. Then, QuickVina 2 is used for molecular docking between the proteins and drugs. After docking, we use PageRank to rank single drugs and drug combinations of each group. The ePharmaLib was used for predicting the side effect targets. Given the differences in the weights of different targets, the method can effectively avoid inhibiting beneficial proteins while inhibiting harmful proteins. So it could minimize the conflicts between different doses and be friendly to chronotherapeutics. Besides, this method also has potential in precision medicine for its high compatibility with bioinformatics and promotes the development of pharmacogenomics and bioinfo-pharmacology.

Publisher

Oxford University Press (OUP)

Subject

Molecular Biology,Information Systems

Reference55 articles.

1. Multi-target-directed-ligands acting as enzyme inhibitors and receptor ligands;Rodríguez-Soacha;Eur J Med Chem,2019

2. Multi-target therapeutics for neuropsychiatric and neurodegenerative disorders;Bawa;Drug Discov Today,2016

3. Targeted temperature management for cardiac arrest with nonshockable rhythm;Lascarrou;N Engl J Med,2019

4. Targeted temperature management at 36 °C shows therapeutic effectiveness via alteration of microglial activation and polarization after ischemic stroke;Kim;Transl Stroke Res

5. Resuscitating the globally ischemic brain: TTM and beyond;Hosseini;Neurother J Am Soc Exp Neurother,2020

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Splittable systems in biomedical applications;Biomaterials Science;2024

2. Recent Advances and Challenges in Protein Structure Prediction;Journal of Chemical Information and Modeling;2023-12-18

3. AlphaFold, allosteric, and orthosteric drug discovery: Ways forward;Drug Discovery Today;2023-06

4. AlphaFold2 and its applications in the fields of biology and medicine;Signal Transduction and Targeted Therapy;2023-03-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3